INTRODUCTION
P SA (prostata specific antigen) was under this term for the first time described by Wang in 1979 1 , although the PSA molecule was discovered as early as in 1971, and since 1981 it was related to prostatic carcinoma. Today PSA is considered as one of the most important organospecific tumor markers which found its place in screening and monitoring programs. PSA is serine protease similar to chymotrypsin created by the production of epithelial prostatic cells 2 . It is found in the serum and seminal plasma. In the seminal plasma it is found mainly in a free form or partially, about 5% bound to the C inhibitor. About 75-90% of PSA in serum is bound to the two main inhibitors of alpha-1-aminochymotypsin and alpha-2-macroglobulin, and about 10-15% is found in a free, anbound form 3 . PSA occurs by the production of humane glandular gene for kalikrein localized on the 19 chrosome. Gene for PSA is found in normal, adenomatous and malignant prostatic tissue. Since PSA belongs to the group of extracellular proteases the main physiological substrate for this antigen are gel proteins from seminal vesicles (semenogelin I and II, and the lesser extent fibronectin) 4 . The initial values of PSA following radical prostatectomy can not be measured in majority of patients or they are very low (<0.1 ng/ml). The increase of PSA values in these patients is very significant for the prognosis 5 .
MATERIAL AND METHODS
The values of PSA were determined in 16 patients during preoperative diagnostic procedures. After radical prostatectomy the PSA values were monitored during the postoperative period lasting 6 weeks. Serum samples of the patients were stored at -20 o C until the moment of analysis. PSA was determined by the EIA Dialab test and Abbott Imx test. Serum of 18 patients who underwent cytoprostatectomy were used as controls.
For statistical analysis the correlation test and Student's t-test were used.
RESULTS AND CONCLUSIONS
A good correlation (p<0.001) was obtained in the study group by comparing the PSA values obtained by the EIA Dialab method with the Abbott Imx method. The EIA Dialab test had ~ 4% lower values that the Abbott Imx test (Yx = 0.2049 + 0.96277x; r = 0.9827; the curve 0.96x).
The mean +/-2SD performed ten times with 0 calibrator was used for determing the analytical sensitivity. The analytical sensitivity of EIA Dialab is presented on Table 1 .
The biological sensitivity was determined in serum of 18 patients who underwent cystoprostatectomy. It is presented as the mean +/-2SD on Table 2 . WE investigated 16 patients who underwent radical prostatectomy. The preoperative finding in these patients is presented in Table 3 .
The postoperative PSA values six months after presented in Table 4 Bilateral orchiectopmy was performed in 4 patients who had stage D and PSA values up to 2.5 ng/ml during the postoperative period. After this procedure the PSA value ranged as presented on Table 5 .
Radical prostatectomy is the method of choice for the treatment of localized prostatic carcinoma. Theoretically, after removal of the complete prostatic tissue PSA shoud not be present in the serum. Practically, depending on the sensitivity of various methods for determining PSA, the dynamics of serum PSA values may offer the clinician an usefull information for early detection of persisting tumour. By determining the analytical and biological detection limit we are in the position to investigated the sensitivity of the PSA determination tests. For EIA Dialab test we found that it has a good correlation with the Abbott Imx test for PSA. We may also conclude that cystoprostatectomy is a good mode for determining the biological sensitivity of PSA test. In our case the BDL for EIA Dialab test is o,2 ng/ml. The data obteined in this study indicate that EIA Dialab test can be used as a sensitivity test for monitoring PSA values after radical prostatectomy and for early detection of persistent disease.
SUMMARY
Pra}enje vrednosti PSA nakon radikalne prostatektomije zahteva kori{}enje visoko osetljivih testova sa niskim detekcionim nivom. Mogu}nosti kori{}enja EIA Dialab testa u pra}enju vrednosti PSA posle radikalne prostatektomije u ranom otkrivanje perzistentne bolesti je ispitivana odredjivanjem biolo{kog detekcionog limita (BDL) u serumu bolesnika podvrgnutih cistoprostatektomiji. Dobijene vrednosti su uporedjivane sa Abbot Imx testom koji se koristi za odredjivanje PSA. Utvrdjena je dobra korelacija izmedju vrednosti dobijenih ovim metodama, r = 0.9827 sa regresionom krivom Yx = 0.20463 + 0.96277x. Test je pokazao da nema zna~ajne razlike (p<0.01) izmedju kori{}enih metoda.
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